# Screening and monitoring of diabetic polyneuropathy in clinical practice: present and future with connected devices

**Authors:** Jean-Pascal Lefaucheur

PMC · DOI: 10.3389/fneur.2025.1679277 · Frontiers in Neurology · 2025-10-21

## TL;DR

Connected devices are transforming diabetes care by enabling long-term monitoring of biomarkers, including early detection and tracking of diabetic polyneuropathy.

## Contribution

The paper highlights recent advances in using connected tools for the early diagnosis and monitoring of diabetic polyneuropathy.

## Key findings

- Connected tools like skin temperature and conductance monitors can help track diabetic polyneuropathy at home.
- Remote monitoring is expected to significantly change clinical practice for neuropathy follow-up in diabetes.
- Personalized medicine is being advanced through long-term biomarker tracking in daily life.

## Abstract

New perspectives are opening up today in the management of diabetes thanks to the possibility of measuring, over long periods in daily life, different biomarkers likely to improve glycaemic control, such as continuous glucose monitoring and time-in-range assessment. This is part of personalized medicine. There is therefore a challenge to also benefit from specific biomarkers in the prevention and monitoring of polyneuropathy in diabetics, one of the most common type of peripheral nerve disorder worldwide. This is now possible with the development of connected tools, allowing for example to monitor at home the evolution of skin temperature or conductance at the level of the feet. In this article, the current use and recent advances in laboratory tools for the early diagnosis and objective monitoring of diabetic polyneuropathy and its progression will be presented. The follow-up of neuropathies will undoubtedly be significantly modified in clinical practice in the future, particularly in the context of diabetes, thanks to the use of connected tools and remote monitoring.

## Linked entities

- **Diseases:** diabetic polyneuropathy (MONDO:0001583), diabetes (MONDO:0005015)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), neuropathies (MESH:D009422), peripheral nerve disorder (MESH:D010523), polyneuropathy (MESH:D011115), diabetic polyneuropathy (MESH:D003929)
- **Chemicals:** glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12583224/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12583224/full.md

## References

150 references — full list in the complete paper: https://tomesphere.com/paper/PMC12583224/full.md

---
Source: https://tomesphere.com/paper/PMC12583224